Vendis Capital completed the acquisition of ARCUS Capital-backed BitterLiebe.

Vendis Capital, an independent specialized private equity firm, completed the acquisition of ARCUS Capital- backed BitterLiebe, a direct-to-consumer premium health brand for gastrointestinal supplements in the DACH region. Financial terms were not disclosed. “We are thrilled to partner with Vendis Capital, a seasoned expert in the consumer space, as we accelerate BitterLiebe’s development and international growth. Together, we aim to establish the premier brand for digestive health supplements in Europe,” Andre Sierek, BitterLiebe Co-Founder.